These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 3315143

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.
    Stommel EW, Field NC, Caller TA.
    Med Hypotheses; 2013 Feb; 80(2):142-5. PubMed ID: 23246360
    [Abstract] [Full Text] [Related]

  • 24. Western Pacific ALS-PDC: Evidence implicating cycad genotoxins.
    Spencer PS, Palmer VS, Kisby GE.
    J Neurol Sci; 2020 Dec 15; 419():117185. PubMed ID: 33190068
    [Abstract] [Full Text] [Related]

  • 25. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG, Mash DC.
    Amyotroph Lateral Scler; 2009 Dec 15; 10 Suppl 2():7-20. PubMed ID: 19929726
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.
    Banack SA, Cox PA.
    Neurotox Res; 2018 Jan 15; 33(1):24-32. PubMed ID: 28478528
    [Abstract] [Full Text] [Related]

  • 30. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
    Murch SJ, Cox PA, Banack SA, Steele JC, Sacks OW.
    Acta Neurol Scand; 2004 Oct 15; 110(4):267-9. PubMed ID: 15355492
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Screening for non-protein amino acids in seeds of the Guam cycad, Cycas circinalis, by an improved GC-MS method.
    Oh CH, Brownson DM, Mabry TJ.
    Planta Med; 1995 Feb 15; 61(1):66-70. PubMed ID: 7700995
    [Abstract] [Full Text] [Related]

  • 34. [Lessons from Guam ALS/PDC study].
    Asao H.
    Rinsho Shinkeigaku; 2007 Nov 15; 47(11):717-21. PubMed ID: 18210783
    [Abstract] [Full Text] [Related]

  • 35. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 25-year prospective case-control study.
    Plato CC, Garruto RM, Fox KM, Gajdusek DC.
    Am J Epidemiol; 1986 Oct 15; 124(4):643-56. PubMed ID: 3752057
    [Abstract] [Full Text] [Related]

  • 36. Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989.
    Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, Kurland LT.
    Neuroepidemiology; 2004 Oct 15; 23(4):192-200. PubMed ID: 15272222
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD, Banack SA, Cox PA, Weiss JH.
    Exp Neurol; 2006 Sep 15; 201(1):244-52. PubMed ID: 16764863
    [Abstract] [Full Text] [Related]

  • 39. Seeking environmental causes of neurodegenerative disease and envisioning primary prevention.
    Spencer PS, Palmer VS, Kisby GE.
    Neurotoxicology; 2016 Sep 15; 56():269-283. PubMed ID: 27050202
    [Abstract] [Full Text] [Related]

  • 40. Commentary on: Return of the cycad hypothesis--does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Wilson J, Shaw CA.
    Neuropathol Appl Neurobiol; 2006 Jun 15; 32(3):341-3. PubMed ID: 16640652
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.